H.C. Wainwright Thinks Axovant Sciences’ Stock is Going to Recover


H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Axovant Sciences (NYSE: AXON) today and set a price target of $11. The company’s shares closed yesterday at $2.63, close to its 52-week low of $1.02.

Fein said:

“Valuation and risks. Our $11 PT is based on an equally weighted composite of: (a) $7.59/share, as a 35x multiple of taxed and diluted FY25 GAAP EPS of $0.81 discounted back to and (b) an NPV of $13.76/share (discount rate 12%, growth rate 2.0%). We continue to view further business development (blank check opportunity) as additional optionality to company’s valuation.”

According to TipRanks.com, Fein is a 4-star analyst with an average return of 6.0% and a 48.9% success rate. Fein covers the Healthcare sector, focusing on stocks such as Proteostasis Therapeutics Inc, ACADIA Pharmaceuticals Inc, and Strongbridge Biopharma Plc.

Currently, the analyst consensus on Axovant Sciences is a Hold with an average price target of $7.

See today’s analyst top recommended stocks >>

The company has a one-year high of $27.98 and a one-year low of $1.02. Currently, Axovant Sciences has an average volume of 6.08M.

Based on the recent corporate insider activity of 11 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of AXON in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel therapeutics in the fields of neurology and psychiatry. Its therapeutic focus are Parkinson’s Disease and Lewy Body Dementia.

Read More on AXON:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts